CHL1 is involved in human breast tumorigenesis and progression

Biochemical and Biophysical Research Communications

Volumn 438, Issue 2, 2013, Pages 433-438

  He, Li Hong ^a,b   Ma, Qin ^a   Shi, Ye Hui ^a,b   Ge, Jie ^a,b   Zhao, Hong Meng ^a,b   Li, Shu Fen ^a,b   Tong, Zhong Sheng ^a,b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Breast cancer; Carcinogenesis; CHL1; Progression

Indexed keywords

CLOSE HOMOLOG OF L1; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CANCER INHIBITION; CELL INVASION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; WESTERN BLOTTING;

BREAST CANCER; CARCINOGENESIS; CHL1; PROGRESSION;

ANIMALS; BREAST NEOPLASMS; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; MICE; MICE, SCID; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; RNA, SMALL INTERFERING; TETRAZOLIUM SALTS; THIAZOLES; TUMOR MARKERS, BIOLOGICAL;

VERTEBRATA;

EID: 84882703746     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.07.093     Document Type: Article

References (31)

1. Valentin M.D., da Silva S.D., Privat M., Alaoui-Jamali M., Bignon Y.J. Molecular insights on basal-like breast cancer. Breast Cancer Res. Treat. 2012, 134:21-30.
2. Rakha E.A., El-Sayed M.E., Green A.R., Lee A.H., Robertson J.F., Ellis I.O. Prognostic markers in triple-negative breast cancer. Cancer 2007, 109:25-32.
3. Parker J.S., Mullins M., Cheang M.C., Leung S., Voduc D., Vickery T., Davies S., Fauron C., He X., Hu Z., Quackenbush J.F., Stijleman I.J., Palazzo J., Marron J.S., Nobel A.B., Mardis E., Nielsen T.O., Ellis M.J., Perou C.M., Bernard P.S. Supervised risk predictor of breast cancer based on intrinsic subtypes. J. Clin. Oncol. 2009, 27:1160-1167.
4. Liu H., Focia P.J., He X. Homophilic adhesion mechanism of neurofascin, a member of the L1 family of neural cell adhesion molecules. J. Biol. Chem. 2011, 286:797-805.
5. Long M.J., Wu F.X., Li P., Liu M., Li X., Tang H. MicroRNA-10a targets CHL1 and promotes cell growth, migration and invasion in human cervical cancer cells. Cancer Lett. 2012, 324:186-196.
6. Li Y., Galileo D.S. Soluble L1CAM promotes breast cancer cell adhesion and migration in vitro, but not invasion. Cancer Cell Int. 2010, 10:34.
7. Gavert N., Vivanti A., Hazin J., Brabletz T., Ben-Ze'ev A. L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers. Mol. Cancer Res. 2011, 9:14-24.
8. Raveh S., Gavert N., Ben-Ze'ev A. L1 cell adhesion molecule (L1CAM) in invasive tumors. Cancer Lett. 2009, 282:137-145.
9. Gast D., Riedle S., Schabath H., Schlich S., Schneider A., Issa Y., Stoeck A., Fogel M., Joumaa S., Wenger T., Herr I., Gutwein P., Altevogt P. L1 augments cell migration and tumor growth but not beta3 integrin expression in ovarian carcinomas. Int. J. Cancer 2005, 115:658-665.
10. Jung J., Son Y.S., Park H., Jeon S.K., Lee J.W., Choi S.Y., Kim J.M., Kwon Y.G., Hong H.J., Min J.K. The cell adhesion molecule L1 promotes gallbladder carcinoma progression in vitro and in vivo. Oncol. Rep. 2011, 25:945-952.
11. Tsutsumi S., Morohashi S., Kudo Y., Akasaka H., Ogasawara H., Ono M., Takasugi K., Ishido K., Hakamada K., Kijima H. L1 Cell adhesion molecule (L1CAM) expression at the cancer invasive front is a novel prognostic marker of pancreatic ductal adenocarcinoma. J. Surg. Oncol. 2011, 103:669-673.
12. Tischler V., Pfeifer M., Hausladen S., Schirmer U., Bonde A.K., Kristiansen G., Sos M.L., Weder W., Moch H., Altevogt P., Soltermann A. L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer. Mol. Cancer 2011, 10:127.
13. Ross D.T., Scherf U., Eisen M.B., Perou C.M., Rees C., Spellman P., Iyer V., Jeffrey S.S., Van de Rijn M., Waltham M., Pergamenschikov A., Lee J.C., Lashkari D., Shalon D., Myers T.G., Weinstein J.N., Botstein D., Brown P.O. Systematic variation in gene expression patterns in human cancer cell lines. Nat. Genet. 2000, 24:227-235.
14. Wei M.H., Karavanova I., Ivanov S.V., Popescu N.C., Keck C.L., Pack S., Eisen J.A., Lerman M.I. In silico-initiated cloning and molecular characterization of a novel human member of the L1 gene family of neural cell adhesion molecules. Hum. Genet. 1998, 103:355-364.
15. Angeloni D., Lindor N.M., Pack S., Latif F., Wei M.H., Lerman M.I. CALL gene is haploinsufficient in a 3p- syndrome patient. Am. J. Med. Genet. 1999, 86:482-485.
16. Frints S.G., Marynen P., Hartmann D., Fryns J.P., Steyaert J., Schachner M., Rolf B., Craessaerts K., Snellinx A., Hollanders K., D'Hooge R., De Deyn P.P., Froyen G. CALL interrupted in a patient with non-specific mental retardation: gene dosage-dependent alteration of murine brain development and behavior. Hum. Mol. Genet. 2003, 12:1463-1474.
17. Sakurai K., Migita O., Toru M., Arinami T. An association between a missense polymorphism in the close homologue of L1 (CHL1, CALL) gene and schizophrenia. Mol. Psychiatry 2002, 7:412-415.
18. Senchenko V.N., Krasnov G.S., Dmitriev A.A., Kudryavtseva A.V., Anedchenko E.A., Braga E.A., Pronina I.V., Kondratieva T.T., Ivanov S.V., Zabarovsky E.R., Lerman M.I. Differential expression of CHL1 gene during development of major human cancers. PLoS One 2011, 6:e15612.
19. Kamiguchi H., Lemmon V. IgCAMs: bidirectional signals underlying neurite growth. Curr. Opin. Cell Biol. 2000, 12:598-605.
20. Hortsch M. Structural and functional evolution of the L1 family: are four adhesion molecules better than one?. Mol. Cell Neurosci. 2000, 15:1-10.
21. Thies A., Schachner M., Moll I., Berger J., Schulze H.J., Brunner G., Schumacher U. Overexpression of the cell adhesion molecule L1 is associated with metastasis in cutaneous malignant melanoma. Eur. J. Cancer 2002, 38:1708-1716.
22. Rokman A., Baffoe-Bonnie A.B., Gillanders E., Fredriksson H., Autio V., Ikonen T., Gibbs K.D., Jones M., Gildea D., Freas-Lutz D., Markey C., Matikainen M.P., Koivisto P.A., Tammela T.L., Kallioniemi O.P., Trent J., Bailey-Wilson J.E., Schleutker J. Hereditary prostate cancer in Finland: fine-mapping validates 3p26 as a major predisposition locus. Hum. Genet. 2005, 116:43-50.
23. Manderson E.N., Birch A.H., Shen Z., Mes-Masson A.M., Provencher D., Tonin P.N. Molecular genetic analysis of a cell adhesion molecule with homology to L1CAM, contactin 6, and contactin 4 candidate chromosome 3p26pter tumor suppressor genes in ovarian cancer. Int. J. Gynecol. Cancer 2009, 19:513-525.
24. Zecchini S., Bianchi M., Colombo N., Fasani R., Goisis G., Casadio C., Viale G., Liu J., Herlyn M., Godwin A.K., Nuciforo P.G., Cavallaro U. The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium. Cancer Res. 2008, 68:1110-1118.
25. Gavert N., Conacci-Sorrell M., Gast D., Schneider A., Altevogt P., Brabletz T., Ben-Ze'ev A. L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J. Cell Biol. 2005, 168:633-642.
26. Tam G.W., van de Lagemaat L.N., Redon R., Strathdee K.E., Croning M.D., Malloy M.P., Muir W.J., Pickard B.S., Deary I.J., Blackwood D.H., Carter N.P., Grant S.G. Confirmed rare copy number variants implicate novel genes in schizophrenia. Biochem. Soc. Trans. 2010, 38:445-451.
27. Dihne M., Bernreuther C., Sibbe M., Paulus W., Schachner M. A new role for the cell adhesion molecule L1 in neural precursor cell proliferation, differentiation, and transmitter-specific subtype generation. J. Neurosci. 2003, 23:6638-6650.
28. Huang X., Zhu L.L., Zhao T., Wu L.Y., Wu K.W., Schachner M., Xiao Z.C., Fan M. CHL1 negatively regulates the proliferation and neuronal differentiation of neural progenitor cells through activation of the ERK1/2 MAPK pathway. Mol. Cell Neurosci. 2011, 46:296-307.
29. Whale A., Hashim F.N., Fram S., Jones G.E., Wells C.M. Signalling to cancer cell invasion through PAK family kinases. Front. Biosci. 2011, 16:849-864.
30. Eswaran J., Soundararajan M., Knapp S. Targeting group II PAKs in cancer and metastasis. Cancer Metastasis Rev. 2009, 28:209-217.
31. Demyanenko G.P., Halberstadt A.I., Rao R.S., Maness P.F. CHL1 cooperates with PAK1-3 to regulate morphological differentiation of embryonic cortical neurons. Neuroscience 2010, 165:107-115.